ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

November 2019, Vol 76, No. 11, Pages 1271-1401

In This Issue of JAMA Neurology

Highlights

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1271. doi:10.1001/jamaneurol.2018.3016
Viewpoint

Time for Neurologists to Drop the Reflex Hammer on Hypertension

Abstract Full Text
JAMA Neurol. 2019;76(11):1277-1278. doi:10.1001/jamaneurol.2019.2588

This Viewpoint advocates for neurologists to address hypertension, including providing preventive care.

Editorial

100 Years of JAMA Neurology and the Journey Back to the Beginning

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1279-1280. doi:10.1001/jamaneurol.2019.3056

Challenges to Realizing Benefits From More Intensive Blood Pressure Control for Preventing Recurrent Stroke

Abstract Full Text
JAMA Neurol. 2019;76(11):1281-1282. doi:10.1001/jamaneurol.2019.1668

Multiple Pathologic Pathways to Dementia in Football Players With Chronic Traumatic Encephalopathy

Abstract Full Text
JAMA Neurol. 2019;76(11):1283-1284. doi:10.1001/jamaneurol.2019.1089

Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis

Abstract Full Text
JAMA Neurol. 2019;76(11):1285-1287. doi:10.1001/jamaneurol.2019.2445
Original Investigation

Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1298-1308. doi:10.1001/jamaneurol.2019.2244

This cross-sectional study investigates association of white matter rarefaction and cerebrovascular disease with dementia in deceased men older than 40 years who had played football and been found to have chronic traumatic encephalopathy.

Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1309-1318. doi:10.1001/jamaneurol.2019.2167

This randomized clinical trial tests the hypothesis that targeting intensive blood pressure lowering of systolic and diastolic blood pressure less than 120 mm Hg and less than 80 mm Hg, respectively, reduces the rate of stroke recurrence compared with a standard blood pressure–lowering regimen.

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1319-1329. doi:10.1001/jamaneurol.2019.2214

This multicenter longitudinal cohort study of 741 participants uses in vivo β-amyloid cerebrospinal fluid and positron emission tomography findings to track progression of Alzheimer disease across 6 years of follow-up.

Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial

Abstract Full Text
open access
JAMA Neurol. 2019;76(11):1330-1339. doi:10.1001/jamaneurol.2019.1868

This phase 2 randomized clinical trial assesses the efficacy, safety, and tolerability of edonerpic maleate for patients with mild to moderate Alzheimer disease.

Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1340-1351. doi:10.1001/jamaneurol.2019.2462

This case-control study examines neuronal-enriched extracellular vesicles as predictors of Alzheimer disease.

Association of Levels of Specialized Care With Risk of Premature Mortality in Patients With Epilepsy

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1352-1358. doi:10.1001/jamaneurol.2019.2268

This cohort study examines the association between the level of care received by Canadian patients with epilepsy and the risk of premature mortality.

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1359-1366. doi:10.1001/jamaneurol.2019.2137

This cohort study compares changes in serum levels of neurofilament light chains with progression of disease among patients with multiple sclerosis.

Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1367-1374. doi:10.1001/jamaneurol.2019.2044

This population-based parent-offspring heritability study examines the extent of amyotrophic lateral sclerosis heritability and assesses the association of sex with disease transmission

Association of CAG Repeats With Long-term Progression in Huntington Disease

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1375-1385. doi:10.1001/jamaneurol.2019.2368

This study analyzes the decades-long early progression of Huntington disease and its dependence on CAG repeat length.

Brief Report

Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D

Abstract Full Text
JAMA Neurol. 2019;76(11):1386-1390. doi:10.1001/jamaneurol.2019.2711

This cohort study assesses trends in prices, market share, and spending on self-administered disease-modifying therapies for multiple sclerosis in Medicare Part D from 2006 through 2016.

Role of Population Receptive Field Size in Complex Visual Dysfunctions: A Posterior Cortical Atrophy Model

Abstract Full Text
JAMA Neurol. 2019;76(11):1391-1396. doi:10.1001/jamaneurol.2019.2447

This case-control study assesses the association of abnormal population receptive fields in the visual cortex with visual impairments in Israel.

JAMA Neurology Clinical Challenge

Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man

Abstract Full Text
JAMA Neurol. 2019;76(11):1397-1398. doi:10.1001/jamaneurol.2019.3002

A 53-year-man presented with numbness in his right arm and difficulty walking, and a computed tomographic scan showed infiltrative soft tissue within the pericardium and intra-atrial septum and throughout the retroperitoneum. What is your diagnosis?

Research Letter

Trends in Location of Death for Individuals With Cerebrovascular Disease in the United States

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1399-1401. doi:10.1001/jamaneurol.2019.2566

This cohort study examines data from the WONDER database for all deaths attributed primarily to cerebrovascular disease between 2003 and 2017 to examine trends in location of death.

Correction

Error in Figure

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1401. doi:10.1001/jamaneurol.2019.3371
JAMA Neurology Masthead

JAMA Neurology

Abstract Full Text
free access
JAMA Neurol. 2019;76(11):1272. doi:10.1001/jamaneurol.2018.3017
×